Viz.ai is a pioneer in the use of AI algorithms and machine learning to increase access to life-saving treatments. Their AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients, informs critical decisions at the point of care, and helps improve outcomes. They cover more than 220 million lives across 1,400+ hospitals and health systems in the U.S. and Europe.

Chris Mansi

David Golan

Manoj Ramachandran

Viz.ai

SnapMD provides an AI-powered solution for medical communication aimed at healthcare professionals, focusing on efficient message handling to improve patient care outcomes.

SnapMD

WELL Health.ai develops and invests in AI-enabled tools and technologies for healthcare providers, aiming to positively impact health outcomes.

WELL Health.ai

TPWELL AI is involved in providing health management solutions using advanced AI technology, offering services including AI Doctor Symptom Consultation, AI Test Result Consultation, and AI General Consultation. The claims of being revolutionary are self-described.

TPWELL AI

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase access to life-saving treatments, covering more than 220 million lives across 1,400+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients, informs critical decisions at the point of care, and helps improve outcomes. Backed by real-world clinical data, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies.

Threshold

Scale Venture Partners

Susa Ventures

Kleiner Perkins

Greenoaks

Innovation Endeavors

Insight Partners

Sozo Ventures

Tiger Global Management

Google Ventures

As #HispanicHeritageMonth comes to a close, we asked members of #TeamViz what it means to be a leader from the Hispanic and Latinx community.

See Rosa, Eduardo, and Jeffrey's responses.

We stand together on #WorldThrombosisDay united in the fight against thrombosis, a leading cause of preventable deaths worldwide. At Viz.ai, we're committed to improving thrombosis detection and patient outcomes with cutting-edge #AI solutions. Together, we can make a difference! 
 #StopTheClot #AIinMedicine #WTDay23

#HLTH2023 was an outstanding success, culminating in our networking event on Monday night, where in-depth discussions revolved around the future of #AI for #BioPharma and #Healthcare.

We're excited for HLTH 2024 already! 
#HealthTech #AIinHealthCare

📺  Join our upcoming webinar on Thursday, October 26 @ 4:00 pm ET to learn about the impact of AI on stroke care and the real-world implications #AI accuracy has on clinical outcomes.  🧠  

Our expert speakers include Mohamad Ezzeldin MD of UTHealth Houston Stroke and Ameer hassan, DO, Valley Baptist Health System, hosted by Viz.ai's Stephanie Vasquez-Mostofi.

Save your spot today: https://lnkd.in/g98PuK8N

#StrokeCare #AIinHealthcare #CareCoordination #AccuracyMatters

Great catching up with Dr Chris Mansi CEO at Viz.ai - listen to Chris’s insight on #GenerativeAI applications in #Healthcare HOPPR #HLTH2023

Thanks to everyone who joined Infinitus, Viz.ai, and Kleiner Perkins at last night's healthcare AI panel discussion at HLTH 2023! 

Infinitus marketing lead Katie Byrne moderated a fascinating discussion with CEO and Co-Founder Ankit Jain and Viz.ai's CEO Dr Chris Mansi. Together, Infinitus and Viz.ai are reducing the waste and wait time for patients to get on, and stay on, therapies. 

If you missed us last night, you can still learn more about how AI is saving the US healthcare system hundreds of thousands of hours every year. Link in the comments below ⬇️

Can AI help mitigate pharma’s losses from lost patients? 

When patients fall through the cracks of a complex care continuum, drug
companies absorb the opportunity costs. Here’s why experts think AI could help recapture those losses: https://lnkd.in/gDsp2B9c

Fierce Pharma #Biopharma #CareCoordination #PatientsFirst

💡 Count the number of times AI is mentioned in your next meeting. If it's not taking center stage in your discussions, let's begin right here. 

This is the first edition of innovizion, a newsletter designed to keep you informed on how AI is emerging as the key driver of innovation in #biopharma and #healthcare. So are you AI-ready? 

Subscribe to stay in the loop! https://lnkd.in/gpVPEQfP

In this recent MedCity News article Mesha Martinez, MD, Moleen Madziva, PhD, and Toni-Moi Prince, PhD discuss health equity in clinical research and how AI can be instrumental in the next step of overcoming unconscious biases inherent in clinical trial processes.

“Something this important deserves the power of AI and the efforts of all!” - Mesha Martinez, MD

#HealthEquity #AI #ClinicalTrials

Read more: https://lnkd.in/ebEkJPZr

We’re thrilled to announce that we have been nominated for the California Life Sciences (CLS) #Pantheon2023 Medtech, Digital, and Diagnostic award! We’re honored to be recognized among other game changers transforming California #lifesciences. 🗳 VOTE by Oct 13: https://lnkd.in/ewrA47BB

Metric
Company Name	Viz.ai	SnapMD	WELL Health.ai	TPWELL AI
Symbol
MSH ID	AI:VIZ	AI:SNAPMD	AI:WELLHEALTH	COM:TPWELLAI
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Technology	Healthcare & Health Services	Healthcare & Health Services
Industry	Hospitals and Health Care	Healthcare & Health Services	Healthcare Technology	Health Technology
Country	US	US	CA	AU
Stage	Venture Round	Series B	Seed
Employee Count	251
Website	viz.ai	snapmd.ai	wellhealth.ai	tpwellai.com/contact-us
LinkedIn	viz.ai		wellhealthtechnologiescorp
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	13.89K	99	1
Web Traffic Growth	-0.25		-0.99
Valuation
Raised Capital		7.10M	1.20M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AI:VIZ

Viz.ai

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue